Weiqiang Zhao MD, PhD


Weiqiang Zhao MD, PhD
Asst Professor - ClinicalCollege of Medicinezhao.186@osu.edu
1000 Polaris 2001 Polaris Parkway Columbus Ohio 43240
Phone:614-293-4210Fax: 614-293-7013
  • Molecular Biology and Cancer Genetics

Current Publications

  • Byrd JCProlonged lymphocytosis during ibrutinib therapy is associated with distinct molecular characteristics and does not indicate a suboptimal response to therapy.Blood 123 1810-7 3/20/2014
  • Wang QEDNA Damage-Binding Complex Recruits HDAC1 to Repress Bcl-2 Transcription in Human Ovarian Cancer Cells.Mol Cancer Res 12 370-80 3/1/2014
  • Blum KAComplete response to induction therapy in patients with Myc-positive and double-hit non-Hodgkin lymphoma is associated with prolonged progression-free survival.Cancer 2/27/2014
  • Wang QEDDB2 Suppresses Tumorigenicity by Limiting the Cancer Stem Cell Population in Ovarian Cancer.Mol Cancer Res 2/26/2014
  • Hofmeister CC, Poi M, Bowers MA, Zhao W, Phelps MA, Benson DM, Kraut EH, Farag S, Efebera YA, Sexton J, Lin TS, Grever M, Byrd JCA phase I trial of flavopiridol in relapsed multiple myeloma.Cancer Chemother Pharmacol 73 249-57 2/1/2014
  • Byrd JCIbrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: an open-label, multicentre, phase 1b/2 trial.Lancet Oncol 15 48-58 1/1/2014
  • Zynger DLER and PR Immunohistochemistry and HER2 FISH versus Oncotype DX: Implications for Breast Cancer Treatment.Breast J 20 37-45 1/1/2014
  • Jones JA, Ruppert AS, Zhao W, Lin TS, Rai K, Peterson B, Larson RA, Marcucci G, Heerema NA, Byrd JCPatients with chronic lymphocytic leukemia with high-risk genomic features have inferior outcome on successive Cancer and Leukemia Group B trials with alemtuzumab consolidation: subgroup analysis from CALGB 19901 and CALGB 10101.Leuk Lymphoma 54 2654-9 12/1/2013
  • Hertlein E, Beckwith KA, Lozanski G, Chen TL, Towns WH, Johnson AJ, Lehman A, Ruppert AS, Bolon B, Andritsos L, Lozanski A, Rassenti L, Zhao W, Jarvinen TM, Senter L, Croce CM, Symer DE, de la Chapelle A, Heerema NA, Byrd JCCharacterization of a new chronic lymphocytic leukemia cell line for mechanistic in vitro and in vivo studies relevant to disease.PLoS One 8(10) e76607 10/9/2013
  • Zhao WHemophagocytosis in a patient with persistent chronic lymphocytic leukemia.Blood 122(13) 2149 9/26/2013
  • Yearsley MM, Frankel WL, Zhou XP, Zhao W, Huang CCLeft-sided sessile serrated polyps/adenomas--reply.Hum Pathol 44(9) 1960-1 9/1/2013
  • Byrd JC, Furman RR, Coutre SE, Flinn IW, Burger JA, Blum KA, Grant B, Sharman JP, Coleman M, Wierda WG, Jones JA, Zhao W, Heerema NA, Johnson AJ, Sukbuntherng J, Chang BY, Clow F, Hedrick E, Buggy JJ, James DF, O'Brien STargeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia.N Engl J Med 369(1) 32-42 7/4/2013
  • Huang CC, Frankel WL, Doukides T, Zhou XP, Zhao W, Yearsley MMProlapse-related changes are a confounding factor in misdiagnosis of sessile serrated adenomas in the rectum.Hum Pathol 44(4) 480-6 4/1/2013
  • Villalona-Calero MAAssessment of FANCD2 nuclear foci formation in paraffin-embedded tumors: a potential patient-enrichment strategy for treatment with DNA interstrand crosslinking agents.Transl Res 161(3) 156-64 3/1/2013
  • Gurcan MNInter-reader variability in follicular lymphoma grading: Conventional and digital reading.J Pathol Inform 4 30 1/1/2013
  • Rose JS, Serna DS, Martin LK, Li X, Weatherby LM, Abdel-Misih S, Zhao W, Bekaii-Saab TInfluence of KRAS mutation status in metachronous and synchronous metastatic colorectal adenocarcinoma.Cancer 118(24) 6243-52 12/15/2012
  • Bueso-Ramos CEOver-expression of CYP2E1 mRNA and protein: implications of xenobiotic induced damage in patients with de novo acute myeloid leukemia with inv(16)(p13.1q22); CBFβ-MYH11.Int J Environ Res Public Health 9(8) 2788-800 8/1/2012

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 300 W. 10th Ave. Columbus, OH 43210 Phone: 1-800-293-5066 | Email: jamesline@osumc.edu